StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.88−0.02 (-2.58%)

Close on Nov 19, 2026Market cap $101.51MP/E –Yield –

NovaBridge Biosciences shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NovaBridge Biosciences's shares outstanding was 266M at Dec 31, 2025. For fiscal 2025 it was 220M, up 18.0% from the year before. The highest annual figure on record is 220M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025220M+18.0%
FY2024Dec 31, 2024187M-2.5%
FY2023Dec 31, 2023191M+0.9%
FY2022Dec 31, 2022190M+8.6%
FY2021Dec 31, 2021175M+11.1%
FY2020Dec 31, 2020157M+2030.2%
FY2019Dec 31, 20197M+13.1%
FY2018Dec 31, 20187M+13.7%
FY2017Dec 31, 20176M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025266M+6.9%
Q3 FY2025Sep 30, 2025240M+2906.3%
Q4 FY2024Dec 31, 2024187M–
Q3 FY2024Sep 30, 2024187M–
Q4 FY2020Dec 31, 2020249M–
Q4 FY2019Dec 31, 20198M–

More NovaBridge Biosciences figures

See a number that looks wrong?